“Effectiveness and Safety of Tuberculin Purified Protein Derivative for the Treatment of Anogenital Warts in Patients With Human Immunodeficiency Virus”. Dermatology Reports, vol. 16, no. 3, Jan. 2024, https://doi.org/10.4081/dr.2024.9754.